Arcus Biosciences RCUS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's accounts payable?
- Arcus Biosciences (RCUS) reported accounts payable of $39M in Q1 2026.
- How has Arcus Biosciences's accounts payable changed year-over-year?
- Arcus Biosciences's accounts payable increased by 77.3% year-over-year, from $22M to $39M.
- What is the long-term trend for Arcus Biosciences's accounts payable?
- Over 5 years (2020 to 2025), Arcus Biosciences's accounts payable has grown at a 21.8% compound annual growth rate (CAGR), from $15.68M to $42M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.